GMO SERIES TRUST AMENDMENT NO. 2 TO AMENDED AND RESTATED AGREEMENT AND DECLARATION OF TRUSTAmended and Restated Agreement and Declaration of Trust • December 19th, 2014 • GMO Series Trust
Contract Type FiledDecember 19th, 2014 CompanyThe undersigned, constituting at least a majority of the trustees of GMO Series Trust, a Massachusetts business trust created and existing under an Amended and Restated Agreement and Declaration of Trust dated September 13, 2011 (the “Declaration of Trust”), as amended from time to time, a copy of which is on file in the Office of the Secretary of The Commonwealth of Massachusetts, hereby rescind the establishment and designation of seven series of GMO Series Trust, GMO Developed Word Stock Series Fund, GMO International Core Equity Series Fund, GMO International Growth Equity Series Fund, GMO International Large/Mid Cap Value Series Fund, GMO U.S. Equity Allocation Series Fund, GMO U.S. Growth Equity Series Fund, and GMO U.S. Intrinsic Value Series Fund, and, having determined that it is desirable and appropriate and consistent with the fair and equitable treatment of all shareholders to change the name of the following series of GMO Series Trust: (i) “GMO International Opportunities
GMO SERIES TRUST AMENDMENT NO. 2 TO AMENDED AND RESTATED AGREEMENT AND DECLARATION OF TRUSTAmended and Restated Agreement and Declaration of Trust • June 27th, 2014 • GMO Series Trust
Contract Type FiledJune 27th, 2014 CompanyThe undersigned, constituting at least a majority of the trustees of GMO Series Trust, a Massachusetts business trust created and existing under an Amended and Restated Agreement and Declaration of Trust dated September 13, 2011 (the “Declaration of Trust”), as amended from time to time, a copy of which is on file in the Office of the Secretary of The Commonwealth of Massachusetts, hereby rescind the establishment and designation of seven series of GMO Series Trust, GMO Developed Word Stock Series Fund, GMO International Core Equity Series Fund, GMO International Growth Equity Series Fund, GMO International Large/Mid Cap Value Series Fund, GMO U.S. Equity Allocation Series Fund, GMO U.S. Growth Equity Series Fund, and GMO U.S. Intrinsic Value Series Fund, and, having determined that it is desirable and appropriate and consistent with the fair and equitable treatment of all shareholders to change the name of the following series of GMO Series Trust: (i) “GMO International Opportunities